Company News

Two doctors sitting and looking at an iPad screen together

Press Release

ION Solutions Collaborates with Grifols to Expand Suite of Pharmacy Offerings for Specialty Physician Practices

March 2021

Press Release

ION & IPN Solutions Collaborate with Annexus Health to Offer AssistPoint to Specialty Physician Practices

October 2020

Industry Spotlights

There’s a new approval and head-to-head trial data for BRUKINSA® (zanubrutinib) now available

September 2021

Explore data for this R_R FL and MZL treatment

September 2021

New enhanced contract for NUBEQA® (darolutamide)

September 2021

NEW! Adjuvant treatment option is now approved

September 2021

FDA-approved treatment in locally advanced BCC

August 2021

See published data in New England Journal of Medicine for 1L aRCC combination therapy

August 2021

New enhanced contract for NUBEQA® (darolutamide)

August 2021

UPDATED DATA INSIDE for a 1L combination for unresectable or metastatic HCC

August 2021

AYVAKIT™ (avapritinib) has a new indication!

August 2021

Strong, continued coverage for your patients

August 2021

Efficacy results for ORGOVYX™ (relugolix)

July 2021

SARCLISA® (isatuximab-irfc): Now approved in a new indication

July 2021

FDA-approved treatment in locally advanced BCC

July 2021

Cardiovascular side effects of CALQUENCE® (acalabrutinib)

July 2021

Updates to NCCN Guidelines® for an AML treatment

July 2021

Treating patients with R/R CLL? Explore the data

June 2021

New data from IMFINZI® (durvalumab)

June 2021

Find important details about clinical study results for first-line CLL treatment.

June 2021

NOW APPROVED for relapsed / refractory RCC

June 2021

Your patients have access to strong coverage

June 2021

What is your treatment approach in advanced ovarian cancer?

June 2021